期刊文献+

二硫化二砷诱导T淋巴细胞白血病细胞株凋亡的机制研究 被引量:1

The mechanism of arsenic sulfide induced apoptosis of T lymphocyte leukemia cells
原文传递
导出
摘要 目的探讨二硫化二砷诱导T淋巴细胞白血病细胞株凋亡的分子机制。方法将不同浓度的二硫化二砷与T淋巴细胞白血病细胞株共培养。采用CCK-8方法测定细胞活性;AnnexinⅤ-PI方法测定细胞凋亡率,采用实时定量PCR在基因水平测定凋亡相关因子Bcl-2和Bax的表达。结果随着二硫化二砷药物浓度的增高,细胞活性减低,随着药物作用时间的延长,细胞活性逐渐减弱。其差异均有统计学意义。细胞凋亡结果显示:二硫化二砷药物浓度越高,细胞凋亡率越高,随着药物作用时间的延长,细胞凋亡率也越高。其差异均有统计学意义。实时荧光定量结果显示:与对照组比较,10μmol/L二硫化二砷与CEM细胞共孵育48 h,Bax/Bcl-2的比例升高(P<0.05)。结论二硫化二砷以时间和剂量依赖的方式抑制CEM细胞生长和诱导凋亡,诱导凋亡的机制与Bax/Bcl-2的比率增加有关。 Objective To investigate the mechanism of arsenic sulfide induced apoptosis of T lymphocyte leukemia cell line CEM. Methods CEM cells were treated with various cor^centrations of Arsenic sulfide for different time periods. Cell viability was detected by the CCK-8 assay, cell apoptosis was examined by flow cytometry. The mRNA level of Bax and Bcl-2 was detected by RT-PCR. Results We found that the T lymphocyte leukemia cells viability was significantly decreased following treatment with Arsenic sulfide for 24 h, 48 h. Along with increasing arsenic sulfide concentration, the cells viability was notably reduced when compared with the control group, and the results were statistically significant. The apoptotic rates of cells were significantly increased at 24 h and 48 h with increasing arsenic sulfide concentration, and were statistically significant. The quantitative real-time PCR results showed that the expression levels of Bax/Bcl-2 ratio were up-regulated in Arsenic sulfide-treated cells. Conclusions Arsenic sulfide inhibited proliferation and induced apoptosis of T lymphocyte leukemia cells in a dose- and time-dependent manner. The mechanism of arsenic sulfide induced apoptosis of T lymphocyte leukemia ceils was related to Bax/Bcl-2 upregulation.
作者 王玲
出处 《中华临床医师杂志(电子版)》 CAS 2013年第20期92-94,共3页 Chinese Journal of Clinicians(Electronic Edition)
关键词 白血病 T细胞 细胞凋亡 BCL-2相关X蛋白质 基因 BCL-2 二硫化二砷 Leukemia, T-cell Apoptosis bcl-2-associated X protein Genes, bcl-2 Arsenicsulfide
  • 相关文献

参考文献2

二级参考文献20

  • 1黄世林,郭爱霞,向阳,王晓波,林慧娴,富丽.复方青黛片为主治疗急性早幼粒细胞白血病的临床研究[J].中华血液学杂志,1995,16(1):26-28. 被引量:185
  • 2Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-abl positive cells. Nat Med, 1996,2:561-566.
  • 3Deininger MW, Goldman JM, Lydon N, et al. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells. Blood, 1997,90:3691-3698.
  • 4Druker BJ, Talpaz M, Resta D, et al. Clinical efficacy and safety of an ABL-specific tyrosine kinase inhibitor as targeted therapy for chronic myelogenous leukemia. Blood, 1999, 94: 386.
  • 5Druker BJ, Sawyers Cl, Kantarjian H, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med, 2001, 344:1038-1042.
  • 6Druker BJ, Talpaz M, Resta DJ, et al. Efficiency and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med, 2001,344: 1031-1037.
  • 7国家药典委员会. 中华人民共和国药典. 第1版. 北京:化学工业出版社,2000. 277.
  • 8Cortez D, Reuther G, Pendergast AM. The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells. Oncogene, 1997,15: 2333-2342.
  • 9Shi CS, Tuscano JM, Witte ON,et al. GCKR links the Bcr-Abl oncogene and Ras to the stress-activated protein kinase pathway. Blood,1999, 93: 1338-1345.
  • 10Skorski T, Kanakaraj P, Nieborowska-Skorska M, et al. Phosphatidylinositol-3 kinase activity is regulated by BCR-ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood,1995, 86: 726-736.

共引文献31

同被引文献21

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部